FeesSafety
Pluang+

Nuwellis to host webinar on ULTRA-Peds study results and Aquadex use in critically ill children

Market News
19 Nov 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
Nuwellis to host webinar on ULTRA-Peds study results and Aquadex use in critically ill children

Nuwellis, Inc. will hold a live webinar on December 1, 2026, to discuss findings from the ULTRA-Peds Registry, a multicenter study on Aquadex therapy in critically ill pediatric patients. The study highlights Aquadex's performance in managing fluid overload in children, with 86% of treatments lasting their planned duration despite common challenges like vascular access issues. The webinar aims to educate healthcare professionals on clinical and technical aspects of ultrafiltration therapy, potentially influencing future pediatric fluid management practices.

Nuwellis Inc (NUWE) shares are trading at USD 3.95 on Pluang as of November 19, 2026, 20:41 WIB, showing a 3.13% increase in one day. The stock has a market cap of $2.07 million and a typical hold time of 34 days on the platform. All current order activity for NUWE on Pluang is buy orders, reflecting strong investor interest at this time.

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App